Targeting hepatocyte-derived factors to improve the efficacy of immunotherapy in pancreatic cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110621
- Recipient
-
The Trustees Of The University Of Pennsylvania UEI GM1XX56LEP58
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $495,379
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from USAspending.gov.
About this award
The Trustees of the University of Pennsylvania were awarded a $495,379 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative biomedical research that investigates medical solutions for battlefield wounds. This award will support The University of Pennsylvania's work developing new immunotherapy approaches for pancreatic cancer by focusing on liver cell-derived factors that influence anti-tumor immune responses.
Quick answers
Who received award W81XWH2110621?
W81XWH2110621 was awarded to The Trustees Of The University Of Pennsylvania by Medical Command (Department of the Army) on September 15, 2021.
How much is award W81XWH2110621 worth?
$495,379 has been obligated on W81XWH2110621.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award